Digestive and Liver Disease
Volume 42, Issue 5 , Pages 377-385 , May 2010

Polycystins play a key role in the modulation of cholangiocyte proliferation

  • Alessia Torrice

      Affiliations

    • Division of Gastroenterology, University of Rome, Sapienza, Rome, Italy
    • ,
  • Vincenzo Cardinale

      Affiliations

    • Division of Gastroenterology, University of Rome, Sapienza, Rome, Italy
    • ,
  • Manuela Gatto

      Affiliations

    • Division of Gastroenterology, University of Rome, Sapienza, Rome, Italy
    • University of Rome Sapienza, Polo Pontino, Latina, Italy
    • ,
  • Rossella Semeraro

      Affiliations

    • Division of Gastroenterology, University of Rome, Sapienza, Rome, Italy
    • University of Rome Sapienza, Polo Pontino, Latina, Italy
    • ,
  • Cristina Napoli

      Affiliations

    • Division of Gastroenterology, University of Rome, Sapienza, Rome, Italy
    • University of Rome Sapienza, Polo Pontino, Latina, Italy
    • ,
  • Paolo Onori

      Affiliations

    • Department of Anatomy, University of Rome Sapienza, Rome, Italy
    • ,
  • Gianfranco Alpini

      Affiliations

    • Central Texas Veterans HCS, Scott & White Digestive Disease Research Center, Dept. Internal Medicine and Systems Biology and Translational Medicine, Texas A&M Health Science Center, College Medicine, at Temple, Temple, TX 76504, United States
    • ,
  • Eugenio Gaudio

      Affiliations

    • Department of Anatomy, University of Rome Sapienza, Rome, Italy
    • ,
  • Domenico Alvaro

      Affiliations

    • Division of Gastroenterology, University of Rome, Sapienza, Rome, Italy
    • University of Rome Sapienza, Polo Pontino, Latina, Italy
    • Corresponding Author InformationCorresponding author at: Division of Gastroenterology, Department of Clinical Medicine, University Sapienza, via R. Rossellini 51, Rome, Italy. Tel.: +39 06 49972023; fax: +39 06 4453319.

Received 24 July 2009 ,Accepted 20 September 2009.

References 

  1. Alvaro D, Mancino MG, Glaser S, et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology. 2007;132:415–431
  2. Alvaro D, Mancino MG. New insights on the molecular and cell biology of human cholangiopathies. Mol Aspects Med. 2008;29:50–57
  3. Glaser SS, Gaudio E, Miller T, et al. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med. 2009;11:e7
  4. Gaudio E, Carpino G, Cardinale V, et al. New insights into liver stem cells. Dig Liver Dis. 2009 [Epub ahead of print].
  5. Alvaro D, Gigliozzi A, Attili AF. Regulation and deregulation of cholangiocyte proliferation. J Hepatol. 2000;33:333–340
  6. Svegliati-Baroni G, Ridolfi F, Caradonna Z, et al. Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis. J Hepatol. 2003;39:528–537
  7. Alvaro D, Onori P, Alpini G, et al. Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. Am J Pathol. 2008;172:321–332
  8. Roskams T. Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus. J Hepatol. 2003;39:431–434
  9. Clouston AD, Powell EE, Walsh MJ, et al. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology. 2005;41:809–818
  10. Lowes KN, Brennan BA, Yeoh GC, et al. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol. 1999;154:537–541
  11. Yang S, Koteish A, Lin H, et al. Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. Hepatology. 2004;39:403–411
  12. Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and non-alcoholic fatty liver disease. Am J Pathol. 2003;163:1301–1311
  13. Masyuk AI, Masyuk TV, Splinter PL, et al. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology. 2006;131:911–920
  14. Huang BQ, Masyuk TV, Muff MA, et al. Isolation and characterization of cholangiocyte primary cilia. Am J Physiol Gastrointest Liver Physiol. 2006;291:G500–G509
  15. Boca M, D’Amato L, Distefano G, et al. Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell mechanical adhesion. Mol Biol Cell. 2007;18:4050–4061
  16. Boca M, Distefano G, Qian F, et al. Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway. J Am Soc Nephrol. 2006;17:637–647
  17. Arnaout MA. Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease. Annu Rev Med. 2001;52:93–123
  18. Koptides M, Deltas CC. Autosomal dominant polycystic kidney disease: molecular genetics and molecular pathogenesis. Hum Genet. 2000;107:115–126
  19. Wu G, Somlo S. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease. Mol Genet Metab. 2000;69:1–15
  20. Alvaro D, Alpini G, Onori P, et al. Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology. 2000;119:1681–1691
  21. Alvaro D, Alpini G, Onori P, et al. Effect of ovariectomy on the proliferative capacity of intrahepatic biliary epithelium. Gastroenterology. 2002;123:336–344
  22. Alvaro D, Onori P, Metalli VD, et al. Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology. 2002;36:297–304
  23. Stokely ME, Hwang SY, Hwang JY, et al. Polycystin-1 can interact with homer 1/Vesl-1 in postnatal hippocampal neurons. J Neurosci Res. 2006;84:1727–1737
  24. Gallagher AR, Cedzich A, Gretz N, et al. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the Actin cytoskeleton. PNAS USA. 2000;97:4017–4022
  25. Diel P, Smolnikar K, Michna H. The pure antiestrogen Ici 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells. Breast Cancer Res Treat. 1999;58:87–97
  26. Surmacz E. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene. 2003;2:6589–6597
  27. Shillingford JM, Murcia NS, Larson CH, et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA. 2006;103:5466–5471
  28. Weimbs T. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?. Cell Cycle. 2006;5:2425–2429
  29. Low SH, Vasanth S, Larson CH, et al. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev Cell. 2006;10:57–69
  30. Masyuk TV, Huang BQ, Ward CJ, et al. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology. 2003;125:1303–1310
  31. Delmas P, Padilla F, Osorio N, et al. Polycystins, calcium signaling, and human diseases. Biochem Biophys Res Commun. 2004;322:1374–1383
  32. Delmas P. Polycystins: polmodal receptor/ion-channel cellular sensors. Pflugers Arch. 2005;451:264–276
  33. Nauli SM, Alenghat FJ, Luo Y, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33:129–137
  34. Praetorius HA, Spring KR. A physiological view of the primary cilium. Annu Rev Physiol. 2005;67:515–529
  35. Ong AC, Wheatley DN. Polycystic kidney disease-the ciliary connection. Lancet. 2003;361:774–776
  36. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med. 1993;329:332–342
  37. Ramos A, Torres VE, Holley KE, et al. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med. 1990;114:180–184
  38. Everson GT. Hepatic cysts in autosomal dominant polycystic kidney disease. Mayo Clin Proc. 1990;65:1020–1025
  39. Everson GT, Emmett M, Brown WR, et al. Functional similarities of hepatic cystic and biliary epithelium: studies of fluid constituents and in vivo secretion in response to secretin. Hepatology. 1990;11:557–565
  40. Perrone RD, Grubman SA, Rogers LC, et al. Continuous epithelial cell lines from ADPKD liver cysts exhibit characteristics of intrahepatic biliary epithelium. Am J Physiol. 1995;269:G335–G345
  41. Nichols MT, Gidey E, Matzakos T, et al. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology. 2004;40:836–846
  42. Fabris L, Cadamuro M, Fiorotto R, et al. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases. Hepatology. 2006;43:1001–1012
  43. Alvaro D, Drudi Metalli V, Alpini G, et al. The intrahepatic biliary epithelium is a target of the growth hormone/insulin like growth factor 1 axis. J Hepatol. 2005;43:875–883
  44. Alvaro D, Alpini G, Onori P, et al. Alfa and beta estrogen receptors and the biliary tree. Mol Cell Endocrinol. 2002;193:105–108
  45. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet. 2004;13:3069–3077
  46. Chauvet V, Tian X, Husson H, et al. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1C terminus. J Clin Invest. 2004;114:1433–1443
  47. Guay-Woodford LM. RIP-ed and ready to dance: new mechanisms for polycystin-1 signaling. J Clin Invest. 2004;114:1404–1406
  48. Selkoe DJ. Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol. 1994;4:708–716
  49. Wolfe MS, Xia W, Ostaszewski BL, et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 1999;398:513–517
  50. Xia W, Wolfe MS. Intramembrane proteolysis by presenilin and presenilin-like proteases. J Cell Sci. 2003;116:2839–2844
  51. McConnell RM, York JL, Frizzell D, et al. Inhibition studies of some serine and thiol proteinases by new leupeptin analogues. J Med Chem. 1993;36:1084–1089
  52. Hook V, Toneff T, Bogyo M, et al. Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease. Biol Chem. 2005;386:931–940
  53. Hook G, Hook VY, Kindy M. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics. Biol Chem. 2007;388:979–983
  54. Iizuka T, Shoji M, Kawarabayashi T, et al. Intracellular generation of amyloid beta-protein from amyloid beta-protein precursor fragment by direct cleavage with beta- and gamma-secretase. Biochem Biophys Res Commun. 1996;218:238–242
  55. Ariyoshi H, Okahara K, Sakon M, et al. Possible involvement of m-calpain in vascular smooth muscle cell proliferation. Arterioscler Thromb Vasc Biol. 1998;18:493–498
  56. Jeon SH, Yoon JY, Park YN, et al. Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via beta-catenin. J Biol Chem. 2007;282:14482–14492
  57. Wolfe MS, Citron M, Diehl TS, et al. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity. J Med Chem. 1998;41:6–9
  58. Wolfe MS. Intramembrane proteolysis. Chem Rev. 2009;109:1599–1612
  59. Kim H, Jeong W, Ahn K, et al. Siah-1 interacts with the intracellular region of polycystin-1 and affects its stability via the ubiquitin-proteasome pathway. J Am Soc Nephrol. 2004;15:2042–2049
  60. Mellgren RL. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20S proteasome. J Biol Chem. 1997;272:29899–29903
  61. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994;78:761–771
  62. Fleisher AS, Raman R, Siemers ER, et al. Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. J Arch Neurol. 2008;65:1031–1038
  63. Wilcock GK, Black SE, Hendrix SB, et al. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. Lancet Neurol. 2008;7:483–493
  64. Ilagan MX, Kopan R. SnapShot: notch signaling pathway. Cell. 2007;128:1246
  65. Rizzo P, Miao H, D'Souza G, et al. Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008;68:5226–5235

☆ Dr. Alpini was supported by the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from Scott & White, the VA Research Scholar Award, and a VA Merit Award; D. Alvaro was supported by MIUR grants: PRIN #2007, prot. 2007HPT7BA_003. E. Gaudio was supported by MIUR grants: PRIN#2007, prot. 2007HPT7BA_001 and Federate Atheneaum funds from University “Sapienza” of Rome.

PII: S1590-8658(09)00394-6

doi: 10.1016/j.dld.2009.09.008

Digestive and Liver Disease
Volume 42, Issue 5 , Pages 377-385 , May 2010

Article Tools

* Image Usage & Resolution